Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Growth Prospects and Strategic Opportunities Through 2029
Uncover key drivers, emerging technologies, and competitive movements shaping the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market from 2025–2034 with trusted insights from The Business Research Company
What CAGR And Valuation Are Anticipated For The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market?
The market size for sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing has seen rapid expansion in recent years. It is forecast to increase from $0.62 billion in 2024 to $0.68 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.1%. The historic period’s growth can be attributed to the rise of telemedicine platforms, increased utilization of electronic health records, a surge in insurance coverage, more community-based testing initiatives, and an expanding array of diagnostic tests.
The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market size is projected to experience substantial growth in the coming years. It is forecast to expand to $0.99 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.8%. This expansion during the forecast period is driven by the increasing global prevalence of sexually transmitted infections, the rising incidence of vaginal infections, the growing number of individuals in reproductive age, and the expanding global population. Prominent trends expected in this period include technological advancements, the widespread adoption of multiplex PCR panels, the integration with telehealth platforms, the incorporation of digital devices, and the availability of self-collected testing kits.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27412&type=smp
What Core Drivers Are Expected To Influence The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market?
The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market is anticipated to expand due to the escalating number of sexual health screenings. These medical examinations are performed to identify sexually transmitted infections (STIs) and associated conditions, ensuring prompt diagnosis, intervention, and prevention of disease transmission. The global increase in the prevalence of sexually transmitted infections has amplified the demand for early detection and timely treatment, consequently driving the rise in sexual health screenings. Such screenings are crucial for STI and vaginitis PCR testing, as they facilitate the early and accurate identification of various infections, often even when symptoms are absent, which supports immediate treatment and helps prevent complications and the spread of infections. For instance, in June 2023, the UK Health Security Agency, a UK-based government body, reported 2,195,909 sexual health screening services for chlamydia, gonorrhea, syphilis, or HIV, marking a 13.4% increase from the 1,936,455 tests conducted in 2021. Therefore, the growth of the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market is being propelled by the increasing sexual health screenings.
What Are The Main Segment Classifications In The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market?
The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market covered in this report is segmented
1) By Test Type: Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, Vaginitis Polymerase Chain Reaction (PCR) Panels
2) By Condition: Sexually Transmitted Infections, Vaginal Infections
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Or At-Home Testing, Other End Users
Subsegments:
1) By Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels: Chlamydia Trachomatis Polymerase Chain Reaction, Neisseria Gonorrhoeae Polymerase Chain Reaction, Trichomonas Vaginalis Polymerase Chain Reaction, Herpes Simplex Virus Polymerase Chain Reaction, Human Papillomavirus Polymerase Chain Reaction, Mycoplasma Genitalium Polymerase Chain Reaction, Syphilis Polymerase Chain Reaction, Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
2) By Vaginitis Polymerase Chain Reaction (PCR) Panels: Bacterial Vaginosis Polymerase Chain Reaction, Candida Species Polymerase Chain Reaction, Trichomoniasis Polymerase Chain Reaction, Mixed Vaginitis Polymerase Chain Reaction Panels, Aerobic Vaginitis Polymerase Chain Reaction, Atrophic Vaginitis Polymerase Chain Reaction
How Are Industry Trends Steering The Expansion Of The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market?
Leading companies in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market are concentrating on developing innovative solutions, such as multiplex PCR tests, to enhance diagnostic precision, decrease testing duration, and enable swifter treatment choices. Multiplex polymerase chain reaction (PCR) tests are defined as diagnostic tools capable of identifying multiple pathogens simultaneously from a single sample through a single PCR reaction. As an illustration, in November 2022, Cepheid Inc., a US-based molecular diagnostics company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP), a rapid multiplex PCR test engineered to detect DNA from the three primary causes of vaginal infections, including bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis, utilizing a single vaginal specimen. Delivering results in approximately 60 minutes, this test facilitates quicker and more accurate diagnosis in symptomatic women, supporting targeted treatments that help reduce treatment failures and unnecessary antibiotic use. Compatible with Cepheid’s GeneXpert systems, it improves clinical decisions and patient outcomes by rapidly identifying co-infections at the point of care.
Which Companies Are Contributing Significantly To The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Growth?
Major companies operating in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd., Sinochips Diagnostics Co Ltd., Vitassay S.L., and Bioperfectus Technologies Co. Ltd.
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Expansion?
North America was the largest region in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in 2024. The regions covered in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=27412&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market 2025, By The Business Research Company
Car Rental Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/car-rental-global-market-report
Car Insurance Aggregators Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/car-insurance-aggregators-global-market-report
Automotive Usage Based Insurance Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
